Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Tanimoto

Showing results (71-80 of 353) with videos related to

Pageof 36
Sort By:
Nature|August 29, 2014
Misconduct: Japan to learn from biomedical casesTetsuya Tanimoto, Masahiro Kami, Kenji Shibuya
JAMA Internal Medicine|July 12, 2021
The Coverage in England of US-Approved Cancer DrugsTakanao Hashimoto, Akihiko Ozaki, Tetsuya Tanimoto
JAMA|July 27, 2021
Blinatumomab vs Chemotherapy Among Children With Relapsed Acute Lymphoblastic LeukemiaMotoharu Shibusawa, Keisuke Kidoguchi, Tetsuya Tanimoto
JAMA|April 12, 2017
Zoledronic Acid Dosing Interval for Metastatic CancerTetsuya Tanimoto, Kenji Tsuda, Jinichi Mori
Diabetes, Obesity & Metabolism|May 15, 2024
Japan initiates market authorization of weight-loss drug semaglutide under universal health coverage, but with stringent prescription restrictionsHayase Hakariya, Mutsuko Ohnishi, Tetsuya Tanimoto
The New England Journal of Medicine|November 12, 2010
Sipuleucel-T immunotherapy for castration-resistant prostate cancerTetsuya Tanimoto, Akiko Hori, Masahiro Kami
Annals of Surgery|August 20, 2019
Comment on "Organ Preservation in cT2N0 Rectal Cancer After Neoadjuvant Chemoradiation Therapy"Yoshiaki Kanemoto, Tomohiro Kurokawa, Tetsuya Tanimoto
Lancet (London, England)|August 28, 2012
Fear of genetic discrimination in JapanNaoko Murashige, Tetsuya Tanimoto, Eiji Kusumi
The New England Journal of Medicine|October 4, 2013
Eculizumab in atypical hemolytic-uremic syndromeTetsuya Tanimoto, Yasuo Oshima, Masahiro Kami
Lancet (London, England)|January 20, 2020
Prophylactic antibiotics after operative vaginal deliveryKaho Iwabu, Yuto Maeda, Tetsuya Tanimoto
Pageof 36

Showing results (71-80 of 353) with videos related to

Sort By:
Pageof 36
Nature|August 29, 2014
Misconduct: Japan to learn from biomedical casesTetsuya Tanimoto, Masahiro Kami, Kenji Shibuya
JAMA Internal Medicine|July 12, 2021
The Coverage in England of US-Approved Cancer DrugsTakanao Hashimoto, Akihiko Ozaki, Tetsuya Tanimoto
JAMA|July 27, 2021
Blinatumomab vs Chemotherapy Among Children With Relapsed Acute Lymphoblastic LeukemiaMotoharu Shibusawa, Keisuke Kidoguchi, Tetsuya Tanimoto
JAMA|April 12, 2017
Zoledronic Acid Dosing Interval for Metastatic CancerTetsuya Tanimoto, Kenji Tsuda, Jinichi Mori
Diabetes, Obesity & Metabolism|May 15, 2024
Japan initiates market authorization of weight-loss drug semaglutide under universal health coverage, but with stringent prescription restrictionsHayase Hakariya, Mutsuko Ohnishi, Tetsuya Tanimoto
The New England Journal of Medicine|November 12, 2010
Sipuleucel-T immunotherapy for castration-resistant prostate cancerTetsuya Tanimoto, Akiko Hori, Masahiro Kami
Annals of Surgery|August 20, 2019
Comment on "Organ Preservation in cT2N0 Rectal Cancer After Neoadjuvant Chemoradiation Therapy"Yoshiaki Kanemoto, Tomohiro Kurokawa, Tetsuya Tanimoto
Lancet (London, England)|August 28, 2012
Fear of genetic discrimination in JapanNaoko Murashige, Tetsuya Tanimoto, Eiji Kusumi
The New England Journal of Medicine|October 4, 2013
Eculizumab in atypical hemolytic-uremic syndromeTetsuya Tanimoto, Yasuo Oshima, Masahiro Kami
Lancet (London, England)|January 20, 2020
Prophylactic antibiotics after operative vaginal deliveryKaho Iwabu, Yuto Maeda, Tetsuya Tanimoto
Pageof 36